![Martin J. Brown](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin J. Brown
Corporate Officer/Principal bij Stanford University
Actieve functies van Martin J. Brown
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Stanford University | Corporate Officer/Principal | - | - |
Loopbaan van Martin J. Brown
Eerdere bekende functies van Martin J. Brown
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Proacta, Inc.
![]() Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Oprichter | 01-01-2001 | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Proacta, Inc.
![]() Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | Health Technology |
- Beurs
- Insiders
- Martin J. Brown
- Ervaring